List of Field Safety Notices from 28 July to 1 August 2025.
Similar Posts
MHRA Safety Roundup: August 2025
Summary of the latest safety advice for medicines and medical device users
Decentralised Manufacture: UK Guideline of Good Pharmacovigilance Practices
Guidance covering various aspects of pharmacovigilance for authorised and unauthorised medicinal products (Specials and the Early Access to Medicines Scheme (EAMS)).
Class 3 Medicines Recall: Kimmtrak 200 micrograms/mL concentrate for solution for infusion, Immunocore Limited, EL(25)A/28
Immunocore Limited is recalling the batches listed below as a precautionary measure. The recall is due to a decrease in potency identified during stability testing. All other stability test results remain within specification.
Fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances.
Field Safety Notices: 02-06 February 2026
List of Field Safety Notices: 02-06 February 2026
MHRA statement on Pathways clinical trial
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants.